BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

76 filings reported holding 09061GAK7 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q1 2025.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 has 63 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $447M of principal .
Largest 10 bondholders include Voya Investment Management LLC ($69.5M of principal), MACKAY SHIELDS LLC ($54.9M of principal), Wellesley Asset Management ($52.1M of principal), AQR Arbitrage LLC ($44M of principal), BlackRock, Inc. ($35.9M of principal), VICTORY CAPITAL MANAGEMENT INC ($20.2M of principal), BNP PARIBAS FINANCIAL MARKETS ($18.7M of principal), Thrivent Financial for Lutherans ($14.6M of principal), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ($13.8M of principal), and Opti Capital Management, LP ($13.7M of principal).
This table shows the top 63 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.